The enormous advances in nanomedicine and precision medicine in the past two decades has necessitated a growing need for an authoritative and comprehensive reference source that can be relied upon by biomedical researchers, clinicians, pharmaceutical scientists, regulators, and lawyers alike. This stand‐alone, full-color book provides a broad survey of various interconnected topics, all accomplished in a user‐friendly format. Each chapter contains key words, tables and figures in color, future projections, and an extensive list of references. It is intended to be a standalone reference volume that broadly surveys and highlights innovative technologies and advances pertaining to nanomedicine and precision medicine. In addition, it also addresses often-neglected yet key issues such as translational medicine, intellectual property law, FDA regulatory issues, nanomedicine nomenclature and artificial nanomachines—all accomplished in a user-friendly, broad yet interconnected format. The book is essential reading for the novice and expert alike in diverse fields such as medicine, law, genomics, pharmaceutical sciences, biomedical sciences, ethics, and regulatory science. The book’s multidisciplinary approach will attract a global audience. It will serve as a valuable reference resource for the industry, academia, and government.
- A stand‐alone, easily accessible volume that provides a broad survey of various topics pertaining to nanomedicine and precision medicine, with a focus on the interrelationship between the two
- An essential reference for the novice and expert alike in diverse areas such as medicine, personalized medicine, law, biotechnology, nanotechnology, pharmaceutical sciences, drug R&D, and regulatory science
- Highlights specific medical specialities in reference to precision medicine along with the transition of nanomedicine to precision medicine
This book is of particular interest to professionals in the public and private sectors involved in medicine, precision medicine, drug delivery, nanomedicine, biomedical research, drug development, FDA regulatory science, ethics, and patent law; academic researchers and scientists, professors, postdoctoral fellows, graduate and undergraduate students, physicians, engineers, patent lawyers, regulatory personnel, pharmaceutical and biotechnology industry personnel, technology transfer officers, business managers, venture capitalists and policy makers